AI Article Synopsis
- The study investigates the role of MUC17 in pancreatic cancer (PC) progression, particularly under the influence of bile acids (BAs) and human serum from patients with pancreatic ductal adenocarcinoma (PDAC) and obstructive jaundice (OJ).
- Researchers found that higher levels of MUC17 are linked with poorer survival outcomes in PDAC patients, with significantly reduced survival time associated with elevated MUC17 expression.
- In laboratory tests, BAs and human serum treatment increased MUC17 levels and cell proliferation in PDAC cells, while reducing MUC17 led to decreased carcinogenic processes, highlighting MUC17 as a potential new biomarker for prognosis in PC.
Article Abstract
Introduction: Our working group has previously shown that bile acids (BAs) accelerate carcinogenic processes in pancreatic cancer (PC) in which mucin 4 (MUC4) expression has a central role. However, the role of other mucins in PC is less clear, especially in bile-induced cancer progression. The study aim was to investigate expression of MUC17 in BA- or human serum-treated pancreatic ductal adenocarcinoma (PDAC) cell lines.
Methods: Different cell-based assays with RNA silencing/overexpression were used to study the role of MUC17 in cancer progression. Protein expression of MUC17 was evaluated in 55 human pancreatic samples by immunohistochemistry, and Kaplan-Meier survival analysis was used to compare survival curves.
Results: Expression of MUC17 increased in PDAC patients, especially in obstructive jaundice (OJ), and the elevated MUC17 expression associated with poorer overall survival (10.66 ± 1.99 vs. 15.05 ± 2.03 months; log-rank: 0.0497). Treatment of Capan-1 and AsPC-1 cells with BAs or with human serum obtained from PDAC + OJ patients enhanced the expression of MUC17, as well as the proliferative potential of the cells, whereas knockdown of MUC17 alone or in combination with MUC4 decreased BAs-induced carcinogenic processes.
Conclusion: Our results demonstrated that MUC17 has a central role in bile-induced PC progression, and in addition to MUC4, this isoform also can be used as a novel prognostic biomarker.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000541874 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Whole exome-seq and RNA-seq data reveal unique neoantigen profiles in Kenyan breast cancer patients.
Front Oncol
December 2024
Directorate of Research and Innovation, Mount Kenya University, Thika, Kenya.
Background: The immune response against tumors relies on distinguishing between self and non-self, the basis of cancer immunotherapy. Neoantigens from somatic mutations are central to many immunotherapeutic strategies and understanding their landscape in breast cancer is crucial for targeted interventions. We aimed to profile neoantigens in Kenyan breast cancer patients using genomic DNA and total RNA from paired tumor and adjacent non-cancerous tissue samples of 23 patients.
View Article and Find Full Text PDFDevelopment of a Caco-2-based intestinal mucosal model to study intestinal barrier properties and bacteria-mucus interactions.
Gut Microbes
December 2025
Department of Biomolecular Health Sciences, Division of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
The intestinal mucosal barrier is a dynamic system that allows nutrient uptake, stimulates healthy microbe-host interactions, and prevents invasion by pathogens. The mucosa consists of epithelial cells connected by cellular junctions that regulate the passage of nutrients covered by a mucus layer that plays an important role in host-microbiome interactions. Mimicking the intestinal mucosa for assays, particularly the generation of a mucus layer, has proven to be challenging.
View Article and Find Full Text PDFIdentification and validation of serum MUC17 as a non-invasive early warning biomarker for screening of gastric intraepithelial neoplasia.
Transl Oncol
January 2025
Department of Gastroenterology, The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Gastroenterology, Hebei Institute of Gastroenterology, Hebei Clinical Research Center for Digestive Diseases, Shijiazhuang, Hebei, PR China. Electronic address:
Background: The early diagnosis and treatment of Gastric Intraepithelial Neoplasia (GIN) are pivotal for improving the survival rates of patients with gastric cancer (GC). Regrettably, reliable noninvasive biomarkers for GIN screening are currently lacking.
Methods: mRNA data from the GEO database, pan-cancer data from the TCGA database, and a gene list of exocrine proteins were subjected to integrated analysis to identify a noninvasive biomarker for GIN.
MUC17 Is a Potential New Prognostic Biomarker and Promotes Pancreatic Cancer Progression in Obstructive Jaundice.
Oncology
October 2024
Department of Pharmacology and Pharmacotherapy, University of Szeged, Szeged, Hungary.
Article Synopsis
- The study investigates the role of MUC17 in pancreatic cancer (PC) progression, particularly under the influence of bile acids (BAs) and human serum from patients with pancreatic ductal adenocarcinoma (PDAC) and obstructive jaundice (OJ).
- Researchers found that higher levels of MUC17 are linked with poorer survival outcomes in PDAC patients, with significantly reduced survival time associated with elevated MUC17 expression.
- In laboratory tests, BAs and human serum treatment increased MUC17 levels and cell proliferation in PDAC cells, while reducing MUC17 led to decreased carcinogenic processes, highlighting MUC17 as a potential new biomarker for prognosis in PC.
The effect of rs2910686 on ERAP2 expression in IBD and epithelial inflammatory response.
J Transl Med
August 2024
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Background: ERAP2 is an aminopeptidase involved in antigen processing and presentation, and harbor genetic variants linked to several inflammatory diseases such as Inflammatory Bowel Disease (IBD). The lack of an ERAP2 gene homologue in mice has hampered functional studies, and most human studies have focused on cells of hematopoietic origin. Using an IBD biobank as vantage point, this study explores how genetic variation in ERAP2 affects gene expression in human-derived epithelial organoids upon proinflammatory stimulation.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!